His scientific interests lie mostly in Stroke, Internal medicine, Atrial fibrillation, Cardiology and Aspirin. His Stroke research is multidisciplinary, incorporating perspectives in Anesthesia, Surgery, Warfarin, Antithrombotic and Hazard ratio. His Anesthesia research includes elements of Anticoagulant, Complication, Ischemia, Intracerebral hemorrhage and Etiology.
His Atrial fibrillation study combines topics in areas such as Irbesartan, Heart disease and Epidemiology. His study in Cardiology is interdisciplinary in nature, drawing from both Platelet activation, Embolic stroke and Risk factor. His Aspirin research integrates issues from Absolute risk reduction, Cerebral infarction and Vitamin K antagonist.
Robert G. Hart focuses on Stroke, Internal medicine, Cardiology, Atrial fibrillation and Surgery. His Stroke study incorporates themes from Anesthesia, Antithrombotic, Randomized controlled trial, Blood pressure and Physical therapy. His study in the field of Aspirin, Hazard ratio, Lacunar stroke and Embolism is also linked to topics like In patient.
His Aspirin research includes themes of Rivaroxaban and Clinical trial. His studies in Cardiology integrate themes in fields like Embolic stroke and Risk factor. His Atrial fibrillation research is multidisciplinary, incorporating elements of Anticoagulant and Heart disease.
The scientist’s investigation covers issues in Stroke, Internal medicine, Cardiology, Surgery and Randomized controlled trial. He interconnects Aspirin, Physical therapy, Atrial fibrillation and Intensive care medicine in the investigation of issues within Stroke. His work on Clopidogrel as part of his general Aspirin study is frequently connected to Pantoprazole, thereby bridging the divide between different branches of science.
The study incorporates disciplines such as Pediatrics and Heart failure in addition to Atrial fibrillation. His work on Stenosis as part of general Cardiology research is frequently linked to In patient, bridging the gap between disciplines. His work in the fields of Surgery, such as Scoliosis, Deformity, Spinal deformity and Lumbar, overlaps with other areas such as Oswestry Disability Index.
His primary scientific interests are in Stroke, Internal medicine, Surgery, Aspirin and Randomized controlled trial. Robert G. Hart has researched Stroke in several fields, including Platelet aggregation inhibitor, Anesthesia, Pediatrics and Atrial fibrillation. His study looks at the relationship between Atrial fibrillation and fields such as Heart failure, as well as how they intersect with chemical problems.
His Internal medicine research incorporates elements of Placebo and Cardiology. Robert G. Hart works mostly in the field of Surgery, limiting it down to concerns involving Quality of life and, occasionally, Physical therapy, Severity of illness and Retrospective cohort study. His work deals with themes such as Hyperintensity and Clinical trial, which intersect with Aspirin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
Robert G. Hart;Lesly A. Pearce;Maria I. Aguilar.
Annals of Internal Medicine (2007)
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.
William M. Feinberg;Joseph L. Blackshear;Andreas Laupacis;Richard Kronmal.
JAMA Internal Medicine (1995)
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
Stuart J. Connolly;Janice Pogue;Robert G. Hart;Stefan H. Hohnloser.
The New England Journal of Medicine (2009)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly;John Eikelboom;Campbell Joyner;Hans-Christoph Diener.
The New England Journal of Medicine (2011)
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
Robert G. Hart;Oscar Benavente;Ruth McBride;Lesly A. Pearce.
Annals of Internal Medicine (1999)
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Larry B. Goldstein;Cheryl D. Bushnell;Robert J. Adams;Lawrence J. Appel.
Stroke (2011)
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.
Larry B. Goldstein;Robert Adams;Mark J. Alberts;Lawrence J. Appel.
Circulation (2006)
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III Randomised Clinical Trial
J. L. Blackshear;V. S. Baker;F. Rubino;R. Safford.
The Lancet (1996)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais.
The New England Journal of Medicine (2017)
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Larry B. Goldstein;Cheryl D. Bushnell;Robert J. Adams;Lawrence J. Appel.
Stroke (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Population Health Research Institute
Population Health Research Institute
Duke University
Hospital for Special Surgery
University of California, San Francisco
McMaster University
Population Health Research Institute
National University of Ireland, Galway
University of Liverpool
Weill Cornell Medicine
Stanford University
Centre national de la recherche scientifique, CNRS
University of Michigan–Ann Arbor
Environment and Climate Change Canada
JEOL (Japan)
University of California, Berkeley
Radboud University Nijmegen
Centre national de la recherche scientifique, CNRS
University of Foggia
Colorado State University
ETH Zurich
Boise State University
University of the Republic
Memorial Sloan Kettering Cancer Center
University of Strathclyde
Nuffield Orthopaedic Centre